Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Correlative Analyses from MajesTEC-1

Autor: Cortes-Selva, Diana *, Casneuf, Tineke *, Vishwamitra, Deeksha *, Stein, Sarah *, Perova, Tatiana *, Skerget, Sheri *, Ramos, Elena *, van Steenbergen, Laure *, De Maeyer, Dries *, Boominathan, Rengasamy *, Lau, Onsay *, Davis, Cuc *, Banerjee, Arnob *, Stephenson, Tara *, Uhlar, Clarissa M. *, Kobos, Rachel, Goldberg, Jenna D. *, Pei, Lixia *, Trancucci, Danielle *, Girgis, Suzette, Wang Lin, Shun Xin *, Wu, Liviawati S. *, Moreau, Philippe *, Usmani, Saad, Bahlis, Nizar Jacques, Van De Donk, Niels WCJ, Verona, Raluca *
Zdroj: In Blood 15 November 2022 140 Supplement 1:241-243
Databáze: ScienceDirect